Budgeting, forecasting and accruing for investigator spend in clinical trials present material challenges for life science companies. Trial sponsors are challenged to account for variation in initiation and performance across sites, asymmetrical distribution of recruitment rates across sites, disparity in rates and lags in data. This playbook provides practical strategies to regain control, visibility and accuracy in forecasting and accruing for investigator spend.
